Stockreport

Kiniksa Pharma down 15% on FDA hold on mavrilimumab [Seeking Alpha]

Kiniksa Pharmaceuticals, Ltd. - Class A  (KNSA) 
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm Check Earnings Report
PDF Thinly traded Kiniksa Pharmaceuticals ( KNSA ) is down on below-average volume on the heels of its announcement that the FDA has placed a clinical hold on its [Read more]